신경재활 기기 시장 분석 및 예측 : 유형별, 제품별, 서비스별, 기술별, 컴포넌트별, 용도별, 기기별, 최종 사용자별, 기능별(-2035년)

The global Neurorehabilitation Devices Market is projected to grow from $3.1 billion in 2025 to $7.0 billion by 2035, at a compound annual growth rate (CAGR) of 8.4%. Neurorehabilitation devices market is witnessing strong volume expansion driven by rising neurological disorder burden and rehabilitation demand. Stroke alone affects nearly 795,000 new patients annually in the U.S., creating continuous demand for post-acute neurorehabilitation devices and therapies. Globally, neurological disorders impact around 1 billion people, with a significant share requiring motor and cognitive rehabilitation support. More than 60% of neuro-recovery patients now use assistive rehabilitation devices, including robotic exoskeletons, wearable sensors, and braina"computer interface systems. In clinical practice, thousands of rehabilitation centers worldwide collectively deploy millions of therapy sessions annually using neurorehabilitation equipment, reflecting accelerating procedural adoption. Increasing stroke, Parkinson’s disease, and spinal injury cases are further expanding device utilization volumes across hospitals and home-care settings globally.

The type segment of the neurorehabilitation devices market includes neurostimulation devices, neurorobotic systems, brain-computer interface, wearable devices, non-invasive devices, invasive devices, and others. Among these, neurostimulation devices are the leading subsegment, driven by their wide application in restoring motor and cognitive functions in patients with neurological disorders such as stroke and Parkinson’s disease. Wearable devices are also witnessing strong adoption due to portability, ease of use, and increasing demand for home-based rehabilitation. Meanwhile, brain-computer interface and neurorobotic systems represent the fastest-growing advanced segments, supported by AI integration, precision rehabilitation, and rising demand for highly personalized neurotherapy solutions.

The end user segment of the neurorehabilitation devices market includes hospitals, clinics, rehabilitation centers, home care settings, and others. Among these, rehabilitation centers are the leading subsegment, driven by their specialized infrastructure and strong focus on long-term neurological recovery programs using advanced neurorehabilitation technologies. Hospitals also account for a significant share due to the availability of multidisciplinary care and integration of advanced neurostimulation and robotic systems. Home care settings are emerging as the fastest-growing segment, supported by increasing demand for remote rehabilitation, patient convenience, and wearable neurodevices enabling continuous therapy outside clinical environments. Clinics continue to show steady adoption across routine neurological treatments.

Geographical Overview

North America is the leading region in the neurorehabilitation devices market due to its advanced healthcare infrastructure, high healthcare spending, and strong adoption of innovative neurotechnology. The region has a high prevalence of neurological disorders such as stroke, Parkinson’s disease, and spinal cord injuries, which drives sustained demand for rehabilitation solutions. Strong presence of key medical device manufacturers, well-established rehabilitation centers, and favorable reimbursement systems further support market growth. Continuous R&D investments and early adoption of technologies like neurorobotics, brain-computer interfaces, and wearable rehabilitation devices strengthen its dominance. The United States accounts for the largest share, supported by robust clinical research networks.

Asia-Pacific is the fastest-growing region in the neurorehabilitation devices market, driven by rapidly aging populations, rising neurological disease burden, and increasing healthcare investments. Countries such as China, India, Japan, and South Korea are expanding rehabilitation infrastructure and adopting advanced neurotechnologies. Growing awareness of early rehabilitation, coupled with government initiatives like a “Healthy China 2030,” is boosting demand. The region is also witnessing strong growth in affordable wearable devices, tele-rehabilitation platforms, and home-based care solutions. Expanding private healthcare providers and rising medical tourism further accelerate adoption.

Key Trends and Drivers

Rising Neurological Disorders and Aging Population:

The growing prevalence of neurological disorders such as stroke, Parkinson’s disease, multiple sclerosis, and spinal cord injuries is a major driver of the neurorehabilitation devices market. With an aging global population, the incidence of age-related neurological impairments is increasing significantly, creating sustained demand for advanced rehabilitation solutions. Stroke alone remains one of the leading causes of long-term disability worldwide, requiring extensive post-acute care and motor recovery support. This rising disease burden is pushing healthcare systems to adopt effective neurorehabilitation technologies that can improve functional recovery, enhance patient independence, and reduce long-term healthcare costs associated with chronic disability management.

Integration of Robotics and AI in Neurorehabilitation:

A key trend in the neurorehabilitation devices market is the increasing integration of robotics and artificial intelligence into rehabilitation therapies. Robotic exoskeletons, assistive gait trainers, and AI-driven therapy platforms are being widely adopted to enhance motor recovery in patients with stroke, spinal cord injuries, and neurological disorders. These technologies provide personalized, adaptive therapy by continuously analyzing patient performance and adjusting treatment intensity in real time. This improves rehabilitation outcomes and reduces dependence on manual physiotherapy. Growing demand for precision medicine and automated rehabilitation solutions is accelerating innovation, making neurorehabilitation more efficient, data-driven, and accessible across clinical and home-care settings globally.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Device
• 2.9 Key Market Highlights by Functionality

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Neurostimulation Devices
  • 4.1.2 Neurorobotic Systems
  • 4.1.3 Brain-Computer Interface
  • 4.1.4 Wearable Devices
  • 4.1.5 Non-Invasive Devices
  • 4.1.6 Invasive Devices
  • 4.1.7 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Neuroprosthetics
  • 4.2.2 Exoskeletons
  • 4.2.3 Neurofeedback Systems
  • 4.2.4 Cognitive Training Devices
  • 4.2.5 Virtual Reality Devices
  • 4.2.6 Robotic Systems
  • 4.2.7 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Rehabilitation Therapy
  • 4.3.2 Consultation Services
  • 4.3.3 Training and Education
  • 4.3.4 Maintenance Services
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Artificial Intelligence
  • 4.4.2 Machine Learning
  • 4.4.3 Virtual Reality
  • 4.4.4 Augmented Reality
  • 4.4.5 Internet of Things
  • 4.4.6 Cloud Computing
  • 4.4.7 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Sensors
  • 4.5.2 Actuators
  • 4.5.3 Controllers
  • 4.5.4 Software
  • 4.5.5 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Stroke
  • 4.6.2 Traumatic Brain Injury
  • 4.6.3 Parkinson's Disease
  • 4.6.4 Cerebral Palsy
  • 4.6.5 Multiple Sclerosis
  • 4.6.6 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Hospitals
  • 4.7.2 Clinics
  • 4.7.3 Rehabilitation Centers
  • 4.7.4 Home Care Settings
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Device (2020-2035)
  • 4.8.1 Portable Devices
  • 4.8.2 Fixed Devices
  • 4.8.3 Wearable Devices
  • 4.8.4 Others
• 4.9 Market Size & Forecast by Functionality (2020-2035)
  • 4.9.1 Motor Function Recovery
  • 4.9.2 Cognitive Function Recovery
  • 4.9.3 Speech Therapy
  • 4.9.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Device
    • 5.2.1.9 Functionality
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Device
    • 5.2.2.9 Functionality
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Device
    • 5.2.3.9 Functionality
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Device
    • 5.3.1.9 Functionality
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Device
    • 5.3.2.9 Functionality
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Device
    • 5.3.3.9 Functionality
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Device
    • 5.4.1.9 Functionality
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Device
    • 5.4.2.9 Functionality
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Device
    • 5.4.3.9 Functionality
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Device
    • 5.4.4.9 Functionality
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Device
    • 5.4.5.9 Functionality
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Device
    • 5.4.6.9 Functionality
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Device
    • 5.4.7.9 Functionality
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Device
    • 5.5.1.9 Functionality
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Device
    • 5.5.2.9 Functionality
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Device
    • 5.5.3.9 Functionality
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Device
    • 5.5.4.9 Functionality
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Device
    • 5.5.5.9 Functionality
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Device
    • 5.5.6.9 Functionality
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Device
    • 5.6.1.9 Functionality
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Device
    • 5.6.2.9 Functionality
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Device
    • 5.6.3.9 Functionality
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Device
    • 5.6.4.9 Functionality
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Device
    • 5.6.5.9 Functionality

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Bioness
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Hocoma
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Ekso Bionics
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 ReWalk Robotics
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Neofect
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Aretech
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Tyromotion
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Neuro Rehab VR
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 AlterG
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Motorika
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Bionik Laboratories
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 NeuroMetrix
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Kinestica
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Reha Technology
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Myomo
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 G-Therapeutics
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Rehabtronics
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Reha-Stim Medtec
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us